Position in VTRS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,810,760
+$307,979 QoQ
Shares Held
177,000
-4.5% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#222
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GAMCO INVESTORS, INC. ET AL holds $24,037,863 across 7 Drug Manufacturers - Specialty & Generic names. VTRS ranks #3 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRGO |
PERRIGO Co plc
|
1,363,707 | $14,168,915 | |
| 2 | BHC |
Bausch Health Companies Inc.
|
707,256 | $3,486,772 | |
| 3 | VTRS |
Viatris Inc
This page
|
177,000 | $2,810,760 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
66,100 | $2,239,468 | |
| 5 | ZTS |
Zoetis Inc.
|
12,413 | $891,998 | |
| 6 | LFCR |
Lifecore Biomedical, Inc. De
|
83,800 | $439,950 | |
| 7 | ESPR |
Esperion Therapeutics, Inc.
|
172,500 | $0 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,810,760 | 177,000 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,502,781 | 185,254 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,391,184 | 192,063 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,851,051 | 287,985 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,626,179 | 294,085 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,736,594 | 314,190 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,773,881 | 303,123 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,646,968 | 314,123 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,466,804 | 326,134 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,098,213 | 343,234 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,788,810 | 349,844 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,896,021 | 395,134 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,289,354 | 429,795 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $4,395,984 | 456,963 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,202,763 | 467,454 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $4,903,583 | 575,538 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,225,347 | 690,100 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $7,568,182 | 695,605 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $9,077,831 | 670,941 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $9,101,927 | 671,729 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,325,939 | 582,641 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,809,787 | 344,294 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,933,788 | 209,914 | Shares | Sole | 2021-02-05 | |
| No filing history on record for this holder in this stock. | ||||||